Durga Prasad Beda
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Durga Prasad Beda has a total of 10 co-authors. Here are the top co-authors by number of shared publications:
Anitha L
Deemed be Univ, Gandhi Inst Technol & Management, GITAM Sch Pharm, Dept Pharmaceut Anal, Hyderabad 502329, Telangana, India
1 shared publication- Bhabani Sankar Satapathy
Department of Pharmaceutics, GITAM School of Pharmacy, GITAM Deemed to Be University, Hyderabad Campus, Telangana, India
1 shared publication - Bhukya Vijay Nayak
Department of Pharmaceutical Analysis, GITAM School of Pharmacy GITAM Deemed to be University Hyderabad Telangana India
1 shared publication - Gatadi Srikanth
GITAM School of Pharmacy, GITAM (Deemed to be University)
1 shared publication - Gatadi Srikanth
GITAM School of Pharmacy, GITAM Deemed to be University, Hyderabad campus, Telangana, India
1 shared publication - Jitendra Patel
Department of Pharmacognosy Datta Meghe College of Pharmacy Datta Meghe Institute of Higher Education Deemed to be University Wardha Maharashtra India
1 shared publication
Latest Publications
- Open Access
- 30 April 2025
- Published by Asian Publication Corporation in Asian Journal of Chemistry
- Vol. 37 (5) , 1006-1016
Innovative Non-Pharmacological Therapies for SARS-CoV-2 Infections: Advances, Challenges and Future Directions
The COVID-19 pandemic has necessitated diverse therapeutic approaches, including drug-free therapies to complement pharmaceutical interventions. This review examines the current landscape, challenges and future perspectives of non-drug therapies for COVID-19. Critical approaches include oxygen therapy, mechanical ventilation, prone positioning, physical therapy, nutritional support, psychological support, hydration management and alternative therapies such as acupuncture and phototherapy. Despite their potential, these therapies face significant challenges, including disease variability, resource limitations, patient-specific factors, infection control issues and the need for robust clinical evidence. Future perspectives highlight the technological advancements such as telehealth, wearable devices and artificial intelligence; improved respiratory support systems; integrated multidisciplinary care; extensive public health initiatives; stringent clinical trials; personalized medicine; global health equity; mental health integration; lifestyle modifications and preparedness for future pandemics. Addressing these challenges and leveraging advancements will enhance the effectiveness and accessibility of drug-free therapies, improving patient outcomes and bolstering healthcare resilience against future pandemics.
- 30 April 2025
- Published by Asian Publication Corporation in Asian Journal of Chemistry
- Vol. 37 (5) , 1006-1016
Open AccessInnovative Non-Pharmacological Therapies for SARS-CoV-2 Infections: Advances, Challenges and Future Directions
The COVID-19 pandemic has necessitated diverse therapeutic approaches, including drug-free therapies to complement pharmaceutical interventions. This review examines the current landscape, challenges and future perspectives of non-drug therapies for COVID-19. Critical approaches include oxygen therapy, mechanical ventilation, prone positioning, physical therapy, nutritional support, psychological support, hydration management and alternative therapies such as acupuncture and phototherapy. Despite their potential, these therapies face significant challenges, including disease variability, resource limitations, patient-specific factors, infection control issues and the need for robust clinical evidence. Future perspectives highlight the technological advancements such as telehealth, wearable devices and artificial intelligence; improved respiratory support systems; integrated multidisciplinary care; extensive public health initiatives; stringent clinical trials; personalized medicine; global health equity; mental health integration; lifestyle modifications and preparedness for future pandemics. Addressing these challenges and leveraging advancements will enhance the effectiveness and accessibility of drug-free therapies, improving patient outcomes and bolstering healthcare resilience against future pandemics.
- Open Access
- 20 December 2024
- Published by IntechOpen
Exploring New Frontiers in Alternative Medicine: Insights and Perspectives
This paper examines the rise of alternative medicine, explores its new frontiers, and provides important insights and perspectives. Alternative medicine has become an important complement to traditional medical practices due to the increasing number of people seeking a holistic approach to health, and it is natural this research examines various alternative therapies, such as acupuncture, herbs, chiropractic care, and homeopathy, and tests their effectiveness, safety, and integration into and management of primary health care, e.g., legal issues, scientific evidence, and ability to integrate with traditional medicine. Through a comprehensive review of recent research, expert opinion, and case studies, this paper aims to provide nuanced understandings of the potential and limitations of alternative medicine and highlight its role in the health of the future of the emphasis. The insights gleaned from this study may provide valuable perspectives for health care providers, researchers, and patients considering alternative therapies.
- 20 December 2024
- Published by IntechOpen
Open AccessExploring New Frontiers in Alternative Medicine: Insights and Perspectives
This paper examines the rise of alternative medicine, explores its new frontiers, and provides important insights and perspectives. Alternative medicine has become an important complement to traditional medical practices due to the increasing number of people seeking a holistic approach to health, and it is natural this research examines various alternative therapies, such as acupuncture, herbs, chiropractic care, and homeopathy, and tests their effectiveness, safety, and integration into and management of primary health care, e.g., legal issues, scientific evidence, and ability to integrate with traditional medicine. Through a comprehensive review of recent research, expert opinion, and case studies, this paper aims to provide nuanced understandings of the potential and limitations of alternative medicine and highlight its role in the health of the future of the emphasis. The insights gleaned from this study may provide valuable perspectives for health care providers, researchers, and patients considering alternative therapies.
- Open Access
- 9 December 2024
- Published by IntechOpen
Repurposed Drugs: Current Trends in Drug Discovery
Drug repurposing is a drug discovery strategy that involves identifying new therapeutic uses for existing drugs. Drug repurposing relies on the idea that a limited number of genes or gene products mediate biological processes and that several biological entities—such as transcripts, proteins, and genes—have pleiotropic effects and mediate similar tasks. Recently, drug repurposing has gained attention as a different approach that looks for novel uses for previously approved or rejected commercial medications to address conditions other than those they were designed for. It offers numerous benefits, such as faster development timelines, reduced costs, established safety profiles, and the potential for novel treatments for unmet medical needs. This chapter explains the current trends in drug discovery and future perspectives on repurposed drugs.
- 9 December 2024
- Published by IntechOpen
Open AccessRepurposed Drugs: Current Trends in Drug Discovery
Drug repurposing is a drug discovery strategy that involves identifying new therapeutic uses for existing drugs. Drug repurposing relies on the idea that a limited number of genes or gene products mediate biological processes and that several biological entities—such as transcripts, proteins, and genes—have pleiotropic effects and mediate similar tasks. Recently, drug repurposing has gained attention as a different approach that looks for novel uses for previously approved or rejected commercial medications to address conditions other than those they were designed for. It offers numerous benefits, such as faster development timelines, reduced costs, established safety profiles, and the potential for novel treatments for unmet medical needs. This chapter explains the current trends in drug discovery and future perspectives on repurposed drugs.
- Open Access
- 5 October 2024
- Published by Elsevier in Green Analytical Chemistry
- Vol. 11
Implementation of quality by design and green chemistry principles to validate the stability indicating method on UHPLC for the simultaneous quantification of Glycopyrronium, Fluticasone, Vilanterol in inhaled formulation
- 5 October 2024
- Published by Elsevier in Green Analytical Chemistry
- Vol. 11
Open AccessImplementation of quality by design and green chemistry principles to validate the stability indicating method on UHPLC for the simultaneous quantification of Glycopyrronium, Fluticasone, Vilanterol in inhaled formulation
- Open Access
- 31 December 2023
- Published by Asian Publication Corporation in Asian Journal of Chemistry
- Vol. 36 (1) , 148-160
Characterization of Prasugrel Degradation Profile by Several Oxidative Reagents using HPLC and LC-MS/MS Technique
Prasugrel, a derivative of thienopyridine functions as a prodrug that exerts irreversible inhibition on platelet ADP receptors by specifically targeting the P2Y12 receptor. In pharmaceuticals, the stability of the product plays a crucial role in establishing the shelf life of product. The second common degradation pathway next to hydrolysis is the oxidation. In practice, the oxidative stress studies were carried out using hydrogen peroxide (H2O2), free radicals, oxygen purging, transition metals, singlet oxygen, Fenton reagent, etc. This study compares the oxidative degradation behaviour of prasugrel hydrochloride using different oxidative stressors and was analyzed by HPLC using a method that could separate degradation products individually and from the drug. The degradation products formed under different stress conditions were characterized using LC-TOF-MS/MS. Analysis of accelerated stability samples of prasugrel formulation revealed that the degradation products formed under azobisisobutyronitrile (AIBN) and H2O2 stress conditions were simulated with the stability data. This study on prasugrel showed that the degradation products formed with H2O2 were also observed under hydrolytic conditions. In the pharmaceutical industry, H2O2 is the only oxidative stressor (< 95%) used to study the oxidation degradation of the sample. The present work has demonstrated that AIBN serves as a valuable oxidative stressor for accurately assessing the oxidative stability of drug.
- 31 December 2023
- Published by Asian Publication Corporation in Asian Journal of Chemistry
- Vol. 36 (1) , 148-160
Open AccessCharacterization of Prasugrel Degradation Profile by Several Oxidative Reagents using HPLC and LC-MS/MS Technique
Prasugrel, a derivative of thienopyridine functions as a prodrug that exerts irreversible inhibition on platelet ADP receptors by specifically targeting the P2Y12 receptor. In pharmaceuticals, the stability of the product plays a crucial role in establishing the shelf life of product. The second common degradation pathway next to hydrolysis is the oxidation. In practice, the oxidative stress studies were carried out using hydrogen peroxide (H2O2), free radicals, oxygen purging, transition metals, singlet oxygen, Fenton reagent, etc. This study compares the oxidative degradation behaviour of prasugrel hydrochloride using different oxidative stressors and was analyzed by HPLC using a method that could separate degradation products individually and from the drug. The degradation products formed under different stress conditions were characterized using LC-TOF-MS/MS. Analysis of accelerated stability samples of prasugrel formulation revealed that the degradation products formed under azobisisobutyronitrile (AIBN) and H2O2 stress conditions were simulated with the stability data. This study on prasugrel showed that the degradation products formed with H2O2 were also observed under hydrolytic conditions. In the pharmaceutical industry, H2O2 is the only oxidative stressor (< 95%) used to study the oxidation degradation of the sample. The present work has demonstrated that AIBN serves as a valuable oxidative stressor for accurately assessing the oxidative stability of drug.